Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.8301
-0.0013 (-0.16%)
At close: Sep 15, 2026, 4:00 PM EDT
0.8299
-0.0002 (-0.02%)
Pre-market: Sep 16, 2026, 8:54 AM EDT

Company Description

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors.

Its activities and acquisition strategy span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity.

Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Genenta Science S.p.A.
Genenta Science logo
CountryItaly
Founded2014
IPO DateDec 15, 2021
IndustryConglomerates
SectorIndustrials
Employees9
CEOPierluigi Paracchi

Contact Details

Address:
Via dell’Annunciata 31
Milan, Michigan 20121
Italy
Phone39 02 29 00 10 55
Websitegenenta.com

Stock Details

Ticker SymbolGNTA
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyEUR
IPO Price$11.50
CIK Code1838716
CUSIP Number36870W100
ISIN NumberUS36870W1009
SIC Code2836

Key Executives

NamePosition
Pierluigi ParacchiCo-Founder, Chairman, Chief Executive Officer and GM
Dr. Luigi Naldini M.D., Ph.D.Co-Founder and Chairman of Scientific Advisory Board
Dr. Bernard Rudolph Gentner M.D., Ph.D.CO-Founder and Scientific Advisory Board Member
Richard B. SlanskyPrincipal Financial and Accounting Officer
Gianfranco De NigrisVice President Corporate Development
Dr. Stefania Mazzoleni Ph.D.Director of Program Development
Barbara RegoniniDirector of Finance

Latest SEC Filings

DateTypeTitle
Sep 11, 20266-KReport of foreign issuer
Sep 2, 20266-KReport of foreign issuer
Jul 31, 20266-KReport of foreign issuer
Jul 14, 20266-KReport of foreign issuer
Jul 1, 20266-KReport of foreign issuer
Jun 26, 20266-KReport of foreign issuer
Jun 24, 20266-KReport of foreign issuer
Jun 17, 20266-KReport of foreign issuer
Jun 16, 20266-KReport of foreign issuer
May 29, 20266-KReport of foreign issuer